These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7739409)

  • 21. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 22. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
    Neve RL; McPhie DL; Chen Y
    Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. S182: from worm sperm to Alzheimer's disease.
    Harrison PJ
    Lancet; 1995 Aug; 346(8972):388. PubMed ID: 7623564
    [No Abstract]   [Full Text] [Related]  

  • 24. Cytoplasmic domain of the beta-amyloid protein precursor of Alzheimer's disease: function, regulation of proteolysis, and implications for drug development.
    Kerr ML; Small DH
    J Neurosci Res; 2005 Apr; 80(2):151-9. PubMed ID: 15672415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chaperone signalling complexes in Alzheimer's disease.
    Koren J; Jinwal UK; Lee DC; Jones JR; Shults CL; Johnson AG; Anderson LJ; Dickey CA
    J Cell Mol Med; 2009 Apr; 13(4):619-30. PubMed ID: 19449461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The future of Alzheimer's disease research: a molecular genetic perspective.
    Goate A
    Neurobiol Aging; 1994; 15 Suppl 2():S161-4. PubMed ID: 7700443
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
    Castano EM; Prelli F; Wisniewski T; Golabek A; Kumar RA; Soto C; Frangione B
    Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The amyloid precursor protein and its homologues: structural and functional aspects of native and pathogenic oligomerization.
    Kaden D; Munter LM; Reif B; Multhaup G
    Eur J Cell Biol; 2012 Apr; 91(4):234-9. PubMed ID: 21459473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease.
    Selkoe DJ
    Annu Rev Cell Biol; 1994; 10():373-403. PubMed ID: 7888181
    [No Abstract]   [Full Text] [Related]  

  • 31. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Alzheimer's gene found.
    Barinaga M
    Science; 1995 Jun; 268(5219):1845-6. PubMed ID: 7604254
    [No Abstract]   [Full Text] [Related]  

  • 34. Human apolipoprotein E: the Alzheimer's disease connection.
    Weisgraber KH; Mahley RW
    FASEB J; 1996 Nov; 10(13):1485-94. PubMed ID: 8940294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.
    Haas C; Cazorla P; Miguel CD; Valdivieso F; Vázquez J
    Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):169-75. PubMed ID: 9224643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Alzheimer's dementia and amyloid precursor-protein].
    Blom N; Linnemann D
    Ugeskr Laeger; 1992 Apr; 154(15):1010-5. PubMed ID: 1566508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypochlorite-induced structural modifications enhance the chaperone activity of human α2-macroglobulin.
    Wyatt AR; Kumita JR; Mifsud RW; Gooden CA; Wilson MR; Dobson CM
    Proc Natl Acad Sci U S A; 2014 May; 111(20):E2081-90. PubMed ID: 24799681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of chemical chaperones on oxidative stress and detergent-insoluble species formation following conditional expression of amyloid precursor protein carboxy-terminal fragment.
    Woltjer RL; McMahan W; Milatovic D; Kjerulf JD; Shie FS; Rung LG; Montine KS; Montine TJ
    Neurobiol Dis; 2007 Feb; 25(2):427-37. PubMed ID: 17141508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.